On Monday, Cogent Biosciences Inc (NASDAQ: COGT) opened higher 1.00% from the last session, before settling in for the closing price of $10.98. Price fluctuations for COGT have ranged from $3.72 to $12.61 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 10.02%. Company’s average yearly earnings per share was noted 9.94% at the time writing. With a float of $107.28 million, this company’s outstanding shares have now reached $113.86 million.
Let’s determine the extent of company efficiency that accounts for 205 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Cogent Biosciences Inc (COGT) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Cogent Biosciences Inc is 23.05%, while institutional ownership is 81.54%. The most recent insider transaction that took place on Jul 10 ’25, was worth 24,999,993. In this transaction Director of this company bought 2,777,777 shares at a rate of $9.00, taking the stock ownership to the 9,003,418 shares. Before that another transaction happened on Jan 14 ’25, when Company’s Chief Commercial Officer bought 43,750 for $7.60, making the entire transaction worth $332,412. This insider now owns 45,848 shares in total.
Cogent Biosciences Inc (COGT) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 9.94% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 28.55% during the next five years compared to 10.02% growth over the previous five years of trading.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
Check out the current performance indicators for Cogent Biosciences Inc (COGT). In the past quarter, the stock posted a quick ratio of 5.13.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.38, a number that is poised to hit -0.59 in the next quarter and is forecasted to reach -1.99 in one year’s time.
Technical Analysis of Cogent Biosciences Inc (COGT)
Looking closely at Cogent Biosciences Inc (NASDAQ: COGT), its last 5-days average volume was 6.34 million, which is a jump from its year-to-date volume of 1.99 million. As of the previous 9 days, the stock’s Stochastic %D was 91.91%.
During the past 100 days, Cogent Biosciences Inc’s (COGT) raw stochastic average was set at 96.91%, which indicates a significant increase from 94.64% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.67 in the past 14 days, which was higher than the 0.49 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.60, while its 200-day Moving Average is $7.96. However, in the short run, Cogent Biosciences Inc’s stock first resistance to watch stands at $11.30. Second resistance stands at $11.50. The third major resistance level sits at $11.83. If the price goes on to break the first support level at $10.77, it is likely to go to the next support level at $10.44. Should the price break the second support level, the third support level stands at $10.24.
Cogent Biosciences Inc (NASDAQ: COGT) Key Stats
There are currently 113,856K shares outstanding in the company with a market cap of 1.82 billion. Presently, the company’s annual sales total 0 K according to its annual income of -255,860 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -71,990 K.
